NCT00501020View on ClinicalTrials.gov

Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

June 5, 2001

Primary Completion Date

February 13, 2003

Study Completion Date

February 13, 2003

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY